Transcutaneous Coronary Interventions and the Post-Intervention Period
Keywords:
restenosis, thrombus formation, stenting, balloon angioplasty, cardiorehabilitationAbstract
Transcutaneous coronary interventions (TCI) are a crucial part of modern cardiology and are the primary treatment method for coronary heart disease, particularly acute coronary syndromes (ACS). PCI involves various procedures aimed at restoring coronary artery patency, which, in turn, improves the blood supply to the heart muscle and reduces the risk of myocardial infarction.
In recent decades, PCI has significantly changed the treatment strategy for patients with coronary artery disease. These interventions have become not only an urgent measure for OCS but also an effective treatment method for chronic ischemic heart disease.
However, the success of PCV depends not only on the quality of the procedure itself, but also on the competent management of the patient in the post-intervention period. A key element is proper rehabilitation and prevention of complications such as stenosis, thrombus formation, as well as long-term patient rehabilitation aimed at minimizing cardiovascular risks.
The purpose of this article is to examine the process of performing transcutaneous coronary interventions and the importance of post-intervention monitoring, as well as modern approaches to treating and rehabilitating patients after such interventions.
References
Ahmed K, Jeong MH, Chakraborty R, et al. Contemporary review of the use of bioabsorbable scaffolds in the treatment of coronary artery disease. Cardiovasc Revasc Med. 2022;34:107-116.
Alraies MC, Lee SY, Dibra H, et al. Effect of bivalirudin versus unfractionated heparin in percutaneous coronary intervention on ST-segment elevation myocardial infarction. Am J Cardiol. 2020;125(9):1294-1300.
Baris L, Cornette J, Johnson MR, et al. Peripartum management of acute coronary syndrome with coronary artery dissection: a systematic review of case reports. Catheter Cardiovasc Interv. 2019;94(7):E570-E581.
Byrne RA, Joner M, Kastrati A. Stent thrombosis and restenosis: mechanisms, clinical presentation, and advances in treatment. Eur Heart J. 2022;43(16):1536-1547.
Capodanno D, Angiolillo DJ. Dual antiplatelet therapy after percutaneous coronary intervention: balancing ischemic and bleeding risks. J Am Heart Assoc. 2021;10(8):e021443.
Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289-1367.
Dangas G, Baber U, Sharma S, et al. Optical coherence tomography findings of stent underexpansion in the PROspective multicenter registry of early generation ABSORB bioresorbable vascular scaffolds implantations (PROMIS). Catheter Cardiovasc Interv. 2023;101(1):80-88.
Deb S, Wijeysundera HC, Ko DT, et al. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review. JAMA. 2020;324(13):1330-1341.
Deharo P, Ducrocq G, Bode C, et al. Timing of angiography and outcomes in high-risk patients with non-ST-segment-elevation myocardial infarction undergoing percutaneous coronary intervention: insights from the TAO trial. Circulation. 2021;143(6):582-593.
Fajadet J, Chieffo A. Current management of left main coronary artery disease. Eur Heart J. 2022;43(12):1243-1265.
Farshid A, Chu F, Alraies MC, et al. Mechanisms of post-intervention arterial remodelling. Cardiovasc Res. 2021;117(11):2289-2305.
Feres F, Costa RA, Abizaid A, et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA. 2019;312(23):2510-2522.
